Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
BNT162b2 mRNA新冠疫苗在慢性淋巴细胞白血病患者中的安全性和免疫原性:一项前瞻性研究
期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207221090150
Diamantopoulos, Panagiotis T; Stafylidis, Christos; Vlachopoulou, Dimitra; Kontandreopoulou, Christina-Nefeli; Giannakopoulou, Nefeli; Vardaka, Maria; Mpouhla, Anthi; Mastrogianni, Elpida; Variami, Eleni; Galanopoulos, Athanasios; Pappa, Vasiliki; Psichogiou, Mina; Hatzakis, Angelos; Viniou, Nora-Athina